The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RCEL | -41.11% | -78.18% | -26.25% | -80% |
| S&P | +20.78% | +72.15% | +11.48% | +383% |
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $17.62M | -4.3% |
| Gross Profit | $14.31M | -11.3% |
| Gross Margin | 81.24% | -6.4% |
| Market Cap | $85.71M | -73.0% |
| Market Cap / Employee | $379.24K | 0.0% |
| Employees | 226 | -13.1% |
| Net Income | -$11,621.00K | -0.3% |
| EBITDA | -$9,708.00K | -1.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $10.24M | -27.1% |
| Accounts Receivable | $9.09M | -22.9% |
| Inventory | 6.9 | -4.7% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.14M | -95.3% |
| Short Term Debt | $43.91M | 4779.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -71.40% | -6.8% |
| Return On Invested Capital | -65.05% | -29.8% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4,783.48K | 43.9% |
| Operating Free Cash Flow | -$5,473.72K | 22.9% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 47.68 | -30.59 | -10.55 | -15.78 | -157.50% |
| Price to Sales | 2.98 | 1.86 | 2.00 | 1.46 | -71.90% |
| Price to Tangible Book Value | -200.30 | -13.96 | -7.47 | -8.86 | -130.73% |
| Enterprise Value to EBITDA | -20.52 | -15.89 | -19.41 | -13.67 | -62.02% |
| Return on Equity | -231.0% | -407.5% | -935.7% | -1746.3% | 1045.55% |
| Total Debt | $44.07M | $44.59M | $44.77M | $46.05M | 0.14% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
